GlassScriptPhysician profile
Kyle Huynh
NPI 1366861031
$5,538.16
in general payments reported to CMS, 2019-2025
19 companies · $760 in 2025
The $760 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $790 · 2020: $125 · 2021: $2,473 · 2022: $680 · 2023: $314 · 2024: $395 · 2025: $760.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,470.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,469.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,767.11 | 2019-2023 | |
| Alcon Vision LLC | $357.90 | 2021-2025 | Tryptyr |
| Sun Pharmaceutical Industries INC. | $356.45 | 2019-2025 | Xelpros, Cequa |
| Novartis Pharmaceuticals Corporation | $284.40 | 2019-2023 | |
| Dompe US, INC. | $213.85 | 2021-2025 | Oxervate |
| Shire North American Group INC | $213.46 | 2019 | |
| Harrow Eye, LLC | $200.77 | 2025 | Vevye |
| Allergan, INC. | $181.34 | 2021 | |
| Rxsight INC | $158.05 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Johnson & Johnson Surgical Vision, INC. | $147.84 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $141.98 | 2024 | Envista Mx60 Iol, Envista Aspire Iol, Miebo |
| Abbvie INC. | $129.01 | 2022-2025 | |
| Aerie Pharmaceuticals, INC. | $124.75 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $96.44 | 2025 | Xdemvy |
| Merz Pharmaceuticals, LLC | $44.10 | 2022-2023 | Xeomin |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $43.16 | 2022-2023 | Tyrvaya |
| Biotissue Holdings INC. | $32.61 | 2019-2022 | |
| Thea Pharma INC. | $23.91 | 2025 | Iyuzeh |
| Mallinckrodt Hospital Products INC. | $21.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Huynh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.